European Heart Journal

(The median citation count of European Heart Journal is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-12-01 to 2023-12-01.)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure4585
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)4449
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2503
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2040
2021 ESC/EACTS Guidelines for the management of valvular heart disease1693
2020 ESC Guidelines for the management of adult congenital heart disease786
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy726
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension714
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease703
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus 689
COVID-19 is, in the end, an endothelial disease633
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era629
European Society of Cardiology: Cardiovascular Disease Statistics 2019621
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death506
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the Internatio504
Coronaviruses and the cardiovascular system: acute and long-term implications497
Acute pulmonary embolism and COVID-19 pneumonia: a random association?460
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage423
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin392
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy390
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe368
Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection362
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors357
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases349
Sex differences in heart failure348
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019342
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcircula332
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study322
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?287
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research281
The ‘Digital Twin’ to enable the vision of precision cardiology279
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study277
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis276
European Society of Cardiology: cardiovascular disease statistics 2021265
Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants246
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance245
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Ather244
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force240
COVID-19-related myocarditis in a 21-year-old female patient236
The ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation236
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus234
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial233
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement224
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine221
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery218
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts217
C-reactive protein and clinical outcomes in patients with COVID-19212
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis196
Pulmonary embolism in COVID-19 patients: a French multicentre cohort study188
COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests171
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement167
Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes167
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease163
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyc162
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions162
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study160
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19156
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure o153
Targeting cardiovascular inflammation: next steps in clinical translation152
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)150
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation – Dual versus triple antithrombotic therapy150
Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome147
Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial142
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis141
Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement136
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)136
Typical takotsubo syndrome triggered by SARS-CoV-2 infection134
The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials133
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry129
A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial129
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy128
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)126
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction126
Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes126
The Mediterranean diet, plasma metabolome, and cardiovascular disease risk125
Left bundle branch area pacing outcomes: the multicentre European MELOS study124
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists117
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study116
Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation114
Heart failure drug treatment: the fantastic four113
Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial113
The ESC Clinical Practice Guidelines for the Management of Adult Congenital Heart Disease 2020111
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials109
The physical activity paradox in cardiovascular disease and all-cause mortality: the contemporary Copenhagen General Population Study with 104 046 adults109
Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study108
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial107
Prevalence of statin intolerance: a meta-analysis106
Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair105
Screening for atrial fibrillation: a call for evidence105
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial104
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (104
The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN)103
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials102
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF102
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme100
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis100
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes99
TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery97
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial97
AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial97
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic96
Causal associations of short and long sleep durations with 12 cardiovascular diseases: linear and nonlinear Mendelian randomization analyses in UK Biobank95
Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study95
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis93
Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies93
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies92
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial91
Genome-wide analysis identifies novel susceptibility loci for myocardial infarction91
Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis90
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation89
Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake88
Joint exposure to various ambient air pollutants and incident heart failure: a prospective analysis in UK Biobank88
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up88
Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk87
Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk86
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of ran86
Vulnerable plaques and patients: state-of-the-art86
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves85
The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study85
Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study85
Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort84
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)83
Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial83
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism82
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS81
Electrocardiogram screening for aortic valve stenosis using artificial intelligence80
New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people80
Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome80
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry80
Combination lipid-lowering therapy as first-line strategy in very high-risk patients79
Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA79
Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world78
Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score78
2023 ESC Guidelines for the management of acute coronary syndromes78
Sex differences and temporal trends in aortic dissection: a population-based study of incidence, treatment strategies, and outcome in Swedish patients during 15 years77
Application of artificial intelligence to the electrocardiogram77
Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation75
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a s75
Genetic predisposition to smoking in relation to 14 cardiovascular diseases75
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group74
Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype74
Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry74
High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population74
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study74
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy73
Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis73
Empagliflozin in acute myocardial infarction: the EMMY trial73
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes73
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percuta72
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EA71
Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations71
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis71
Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study71
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial71
The “ten commandments” for the 2021 ESC/EACTS Guidelines on valvular heart disease70
Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial70
Colchicine and the heart70
Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction69
Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR)69
Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry69
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial68
Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis68
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombo67
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial67
Return to sports after COVID-19 infection67
Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction67
Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study67
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials67
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial66
Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance66
Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study65
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies65
Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak64
A practical risk score for early prediction of neurological outcome after out-of-hospital cardiac arrest: MIRACLE264
Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction64
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial64
Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study63
Assessment and pathophysiology of microvascular disease: recent progress and clinical implications63
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammatio63
Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study62
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study62
Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction62
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure61
Fractional flow reserve in clinical practice: from wire-based invasive measurement to image-based computation61
Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease (CHD): position statement of the Sports Cardiology & Exercise Section of the E61
Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translat61
Twitter promotion predicts citation rates of cardiovascular articles: a preliminary analysis from the ESC Journals Randomized Study61
Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study61
Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease61
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis61
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction61
Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study61
Transient complete heart block in a patient with critical COVID-1960
COVID-19: from epidemiology to treatment60
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial60
Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction59
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial59
Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement59
Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with th59
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy59
Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)58
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences58
Frailty and cardiovascular outcomes in the National Health and Aging Trends Study58
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis58
Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study58
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk58
Feasibility of using deep learning to detect coronary artery disease based on facial photo57
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy57
Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole57
The win ratio approach for composite endpoints: practical guidance based on previous experience57
Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality57
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology 57
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the He57
Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data56
Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial56
Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection56
The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a prospective study of 418 329 participants in the EPIC cohort across nine European countries56
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-1956
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality56
Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up55
Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial55
Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention55
Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis55
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy55
Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models55
Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation55
Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective55
TeleCheck-AF for COVID-1955
Does epicardial fat contribute to COVID-19 myocardial inflammation?55
A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs54
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases54
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer—a nationwide analysis54
Assessing left ventricular systolic function: from ejection fraction to strain analysis53
The ‘10 commandments’ for the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy53
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey53
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials53
Genetic variability in the absorption of dietary sterols affects the risk of coronary artery disease53
Risk of hypertension into adulthood in persons born prematurely: a national cohort study53
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study53
Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting52
Brugada syndrome genetics is associated with phenotype severity52
Road traffic noise and cardiovascular disease risk factors in UK Biobank52
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme52
Clinical application of the 4th Universal Definition of Myocardial Infarction52
Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial51
Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial51
Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study51
STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases51
Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score51
Stress-associated neurobiological activity associates with the risk for and timing of subsequent Takotsubo syndrome50
Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics50
Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry50
Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial50
The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms50
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease49
Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?49
Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis48
Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data48
Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study48
The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study48
Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood–brain barrier48
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical 48
The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy48
The struggle towards a Universal Definition of Heart Failure—how to proceed?48
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR47
Tilt testing remains a valuable asset47
Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank47
Effects of canagliflozin on human myocardial redox signalling: clinical implications47
Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis47
Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome47
Circulating stem cells and cardiovascular outcomes: from basic science to the clinic47
Corrigendum to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary s47
Atrial myxomas arise from multipotent cardiac stem cells46
Outdoor light at night and risk of coronary heart disease among older adults: a prospective cohort study46
Sex differences in arterial hypertension46
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial46
Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival46
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death46
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure45
Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis45
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial45
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction45
The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial45
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study45
All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study45
Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR445
Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock45
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade45
Transition to adulthood and transfer to adult care of adolescents with congenital heart disease: a global consensus statement of the ESC Association of Cardiovascular Nursing and Allied Professions (A44
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis44
Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.2344
Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry44
Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled44
Heart healthy cities: genetics loads the gun but the environment pulls the trigger44
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study44
Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?44
Multivessel coronary thrombosis in a patient with COVID-19 pneumonia44
Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study44
Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic44
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis43
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials43
Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure43
Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrilla43
Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study43
Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA42
Sleep arousal burden is associated with long-term all-cause and cardiovascular mortality in 8001 community-dwelling older men and women42
The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions42
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions42
Coexistence and outcome of coronary artery disease in Takotsubo syndrome42
Omics phenotyping in heart failure: the next frontier42
Sudden cardiac death among persons with diabetes aged 1–49 years: a 10-year nationwide study of 14 294 deaths in Denmark42
Association of the combined effects of air pollution and changes in physical activity with cardiovascular disease in young adults42
PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction41
Prognostic value of stress echocardiography assessed by the ABCDE protocol41
Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction40
Adipocytes promote interleukin-18 binding to its receptors during abdominal aortic aneurysm formation in mice40
Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction40
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications40
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia40
Targeting the CCL2–CCR2 axis for atheroprotection40
Vascular responses to coronary calcification following implantation of newer-generation drug-eluting stents in humans: impact on healing40
Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms39
2023 ESC Guidelines for the management of cardiomyopathies39
Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients39
Aetiology and outcomes of severe right ventricular dysfunction39
Reduction of environmental pollutants for prevention of cardiovascular disease: it’s time to act39
Critical appraisal of artificial intelligence-based prediction models for cardiovascular disease39
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy39
Sodium intake, life expectancy, and all-cause mortality39
Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective38
Artificial intelligence in the diagnosis and management of arrhythmias38
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy38
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic38
Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention38
Silent brain infarcts impact on cognitive function in atrial fibrillation38
The dawn of a new era of targeted lipid-lowering therapies37
When genetic burden reaches threshold37
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study37
Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit37
Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney37
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction:37
Impact of sex on the management and outcome of aortic stenosis patients37
Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score37
Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis37
Targeted proteomics improves cardiovascular risk prediction in secondary prevention37
Smoking cessation, but not reduction, reduces cardiovascular disease incidence37
Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice36
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction36
Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial36
Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity36
An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins36
COVID-19 experience in Bergamo, Italy35
Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study35
Twitter-based learning for continuing medical education?35
Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study35
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project35
Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failure35
Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction35
SGLT2 inhibitors: the statins of the 21st century35
Myocardial injury in severe COVID-19 infection35
Physical activity and fitness in the community: the Framingham Heart Study35
Implementing the new European Regulations on medical devices—clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology34
Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study34
A leucopoietic-arterial axis underlying the link between ambient air pollution and cardiovascular disease in humans34
Nomenclature for kidney function and disease—executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference34
Does night-time aircraft noise trigger mortality? A case-crossover study on 24 886 cardiovascular deaths34
Supracardiac atherosclerosis in embolic stroke of undetermined source: the underestimated source34
High-density lipoprotein revisited: biological functions and clinical relevance34
Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Hear33
Accelerated and personalized therapy for heart failure with reduced ejection fraction33
Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006–201533
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology33
Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compaction33
Timing of intervention in asymptomatic patients with valvular heart disease33
Fulminant COVID-19-related myocarditis in an infant33
A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial33
Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population study33
Iron deficiency and cardiovascular disease33
ESC Core Curriculum for the Cardiologist33
Accelerometer-derived physical activity and risk of atrial fibrillation33
Corrigendum to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation32
Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial32
Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study32
Long-term cardiovascular disease mortality among 160 834 5-year survivors of adolescent and young adult cancer: an American population-based cohort study32
2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease32
Ultra-processed food intake and all-cause and cause-specific mortality in individuals with cardiovascular disease: the Moli-sani Study32
Cholesterol crystals and atherosclerosis32
An automated computational image analysis pipeline for histological grading of cardiac allograft rejection32
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm32
Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study32
Peripartum cardiomyopathy: from genetics to management32
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification32
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (32
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized cl32
Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy32
Automated external defibrillators delivered by drones to patients with suspected out-of-hospital cardiac arrest31
Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction31
Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease31
Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study31
Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies31
Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia31
Statin associated lower cancer risk and related mortality in patients with heart failure31
Precision Medicine and cardiac channelopathies: when dreams meet reality31
Importance of genetic testing in unexplained cardiac arrest31
A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast 31
Stress-associated neurobiological activity is linked with acute plaque instability via enhanced macrophage activity: a prospective serial 18F-FDG-PET/CT imaging assessment30
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies30
Trends in survival after cardiac arrest: a Swedish nationwide study over 30 years30
Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?30
Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome30
Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo30
COVID-19 pandemic: a sentiment analysis30
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis30
Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice30
Risk factors for type 1 and type 2 myocardial infarction29
Temporal changes in total and hippocampal brain volume and cognitive function in patients with chronic heart failure—the COGNITION.MATTERS-HF cohort study29
Restrictive cardiomyopathy: definition and diagnosis29
The collateral damage of COVID-19 to cardiovascular services: a meta-analysis29
Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography a29
Vigorous physical activity, incident heart disease, and cancer: how little is enough?29
Lipoproteins in chronic kidney disease: from bench to bedside29
Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics29
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator29
Chronic venous insufficiency, cardiovascular disease, and mortality: a population study29
A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity29
The PROFID project29
Screening in children for familial hypercholesterolaemia: start now29
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial29
The haemochromatosis gene Hfe and Kupffer cells control LDL cholesterol homeostasis and impact on atherosclerosis development29
Myocardial hypoxic stress mediates functional cardiac extracellular vesicle release28
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment28
Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease28
Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy28
The association between coronary graft patency and clinical status in patients with coronary artery disease28
Contribution of income and job strain to the association between education and cardiovascular disease in 1.6 million Danish employees28
Bone marrow activation in response to metabolic syndrome and early atherosclerosis28
Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions28
Trends in aortic valve replacement for aortic stenosis: a French nationwide study28
Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms28
The 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia27
Management of refractory angina: an update27
Pregnancy loss and risk of cardiovascular disease: the Nurses’ Health Study II27
Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study27
Management of non-culprit coronary plaques in patients with acute coronary syndrome27
Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction27
Genome-wide association study identifies 18 novel loci associated with left atrial volume and function27
The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure27
What we (don’t) know about myocardial injury after COVID-1927
Patient-tailored antithrombotic therapy following percutaneous coronary intervention27
Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease27
Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?27
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke27
Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management27
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial27
A call to action for new global approaches to cardiovascular disease drug solutions27
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom26
Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis26
Dapagliflozin for heart failure according to body mass index: the DELIVER trial26
SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?26
Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial26
Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality26
Impact of cholesterol on proinflammatory monocyte production by the bone marrow26
Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF26
Low ambient temperature and temperature drop between neighbouring days and acute aortic dissection: a case-crossover study26
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout26
Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis; an26
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes26
Right ventricular dilatation in arrhythmogenic right ventricular cardiomyopathy: need for a revision of the 2010 International Task Force criteria26
Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study26
Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away26
Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study26
Hypertension in children and adolescents26
Genetic insight into sick sinus syndrome25
Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry25
Prevalence, incidence, and outcomes across cardiovascular diseases in homeless individuals using national linked electronic health records25
One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study25
Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome25
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled25
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients25
Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation25
Pregnancy-associated arterial dissections: a nationwide cohort study25
Obesity and cardiovascular health: the size of the problem25
Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis25
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventio25
Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know25
Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis o25
2023 ESC Guidelines for the management of endocarditis24
Sex associations and computed tomography coronary angiography-guided management in patients with stable chest pain24
Sudden cardiac death in congenital heart disease24
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial24
Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications24
Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials24
Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home24
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy24
Discriminatory cardiac arrest care? Patients with low socioeconomic status receive delayed cardiopulmonary resuscitation and are less likely to survive an in-hospital cardiac arrest24
Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations24
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial24
Insomnia symptoms and incident heart failure: a population-based cohort study24
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 5424
Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies24